WebMD Amends Rights Agreement
NEW YORK, Oct. 19, 2012 /PRNewswire/ -- WebMD Health Corp. (NASDAQ: WBMD) today announced that, on October 18, 2012, its Board of Directors adopted an amendment to the Company's Rights Agreement.
The Rights Agreement was adopted by the WebMD Board on November 2, 2011 to guard against inadequate or coercive takeovers and other tactics that might be used in an attempt to gain control of the Company without paying all stockholders a fair price for their shares. The Rights Agreement does not prevent takeovers, but is designed to deter coercive takeover tactics and to encourage anyone attempting to acquire the Company to negotiate first with the Board. Under the Rights Agreement, WebMD stockholders received rights to purchase shares of a new series of preferred stock in certain circumstances. A description of the Rights Agreement is included in the Current Report on Form 8-K filed by WebMD on November 3, 2011.
The amendment to the Rights Agreement:
- extends the expiration date of the Rights Agreement from October 31, 2012 to October 31, 2014;
- provides that equity compensation awards to directors will not be included in determining whether a stockholder becomes an "Acquiring Person" under the Rights Agreement; and
- decreases the purchase price payable by holders of rights issued under the Rights Agreement upon exercise of such rights from $153.00 to $66.29.
No other changes to the Rights Agreement were made.
The Rights Agreement, as amended, will be presented for ratification by the Company's stockholders at the 2013 Annual Meeting of Stockholders of the Company. About WebMD WebMD Health Corp. (NASDAQ: WBMD) is the leading provider of health information services, serving consumers, physicians, healthcare professionals, employers, and health plans through our public and private online portals, mobile platforms and health-focused publications.Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
